US company Moderna has made a major step in cancer treatment with a new vaccine. The vaccine, developed with Merck, helped reduce the risk of cancer returning in patients with melanoma. After the news, Moderna’s share price jumped by about 177% in one day. The success has raised hopes that mRNA vaccines could become a new way to treat cancer.
